Aktieselskabet Schouw & Co.
Schouw & Co. share buy-back programme, week 13-14 2025
Schouw & Co. share buy-back programme, week 13-14 2025
On 2 January 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 70 of 23 December 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 50 million during the period 2 January to 31 March 2025.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
Trading day | No. of shares | Average price | Amount | ||
Accumulated until 21 March 2025 | 81,300 | 566.19 | 46,030,916 | ||
Monday, 24 March 2025 | 1,000 | 640.03 | 640,030 | ||
Tuesday, 25 March 2025 | 1,000 | 640.96 | 640,960 | ||
Wednesday, 26 March 2025 | 1,000 | 638.01 | 638,010 | ||
Thursday, 27 March 2025 | 1,000 | 630.63 | 630,630 | ||
Friday, 28 March 2025 | 1,200 | 628.31 | 753,972 | ||
Monday, 31 March 2025 | 1,080 | 615.55 | 664,794 | ||
In the period 24 March 2025 - 31 March 2025 | 6,280 | 631.91 | 3,968,396 | ||
Accumulated until 31 March 2025 | 87,580 | 570.90 | 49,999,312 | ||
Following the above transactions, Schouw & Co. holds a total of 2,041,993 treasury shares corresponding to 8.17% of the total share capital of 25,000,000 shares. | |||||
The above transactions conclude the share buy-back programme outlined in Company Announcement no. 70 of 23 December 2024.
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Zymeworks Inc.25.4.2025 19:00:00 CEST | Press release
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Sequana Medical NV25.4.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
Sanoma Corp25.4.2025 17:30:00 CEST | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 25 April 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom